PALM BEACH, Florida, November 28, 2017 /PRNewswire/ --
Market analysts are forecasting steady growth for the Global Condom Industry based on such factors as rise in sexually transmitted diseases, HIV/Aids, incorrect use of contraceptives, unprotected sexual intercourse, contraceptive failures, or sexual assaults which can lead to unplanned pregnancies. According to Global Market Insights, the Global Contraceptives Market is poised cross USD $35 Billion by 2024 on the heels of rising prevalence of sexually transmitted diseases, favorable regulatory scenario in developed nations. The increasing use of contraceptive in under developed countries and rising awareness towards disease prevention will further boost the business size. In the news today includes: RESTANCE, Inc. (OTC: ANCE), Church & Dwight Co., Inc. (NYSE: CHD), Reckitt Benckiser Group plc (OTC: RBGLY), Pfizer Inc. (NYSE: PFE), Pfizer Inc. (NYSE: PFE)
RESTANCE, Inc. (OTC: ANCE) today announced a contract to manufacture condoms with the Playboy brand name and bunny head logo for distribution starting in Kenya. The brand name is being announced today in support of World AIDS Day, coming on December 1, 2017. RESTANCE is participating in a campaign to contribute to the United Nations goal of ending the AIDS Epidemic by making condoms available everywhere in Africa through the #DoIt4Africa buy-one-give-one campaign where an anticipated $20 million in condoms will be sold in North American and for every condom sold, a condom will be manufactured in Africa and given away in Africa. RESTANCE has executed an initial $500,000 contract to produce condoms for the campaign. Look for more details on the #DoIt4Africa campaign coming soon. Read this and more news for RESTANCE at: http://www.marketnewsupdates.com/news/ance.html
In addition to opening a condom manufacturing plant, RESTANCE is pursuing several other business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.
In other industry developments and market performances of note:
Church & Dwight Co., Inc. (NYSE: CHD) closed up slightly on Monday at $45.10 trading over 1.4 Million shares by the market close. TROJAN condoms, manufactured by the Church & Dwight, launched a new XOXO upscale condom targeting both men and women with a soft touch, aloe-lubricated latex in a unique portable carrying case. This launch has opened up new opportunities for condom advertising in prime-time television. Church & Dwight this month reported that its Board of Directors declared a regular quarterly dividend of nineteen cents ($0.19) per share. This quarterly dividend will be payable December 1, 2017 to stockholders of record at the close of business on November 15, 2017. It is the Company's 467th regular consecutive quarterly dividend.
Reckitt Benckiser Group plc (OTC: RBGLY) closed down slightly on Monday at $17.17 by the market close. Reckitt Benckiser's (RB) Durex premire Invisible Ultra Thin is the thinnest condom designed to maximize sensitivity, while still providing a high level of security and protection. RB is a global force in household, health and personal care. Its 19 Powerbrands, in high growth categories, take a disproportionate share of RB's top end marketing investment. Powerbrands drive over 70% of growth.
In other healthcare news:
Pfizer Inc. (NYSE: PFE) closed even on the day on Monday at $35.49 trading over 10.2 Million shares by the market close. Pfizer is now selling the drug directly from the official Viagra website. Men still need a prescription for the diamond-shaped blue pills. But instead of going to the pharmacy in person, or taking their chances buying from an online pharmacy of unknown repute, men will be able to buy Viagra from the maker of the drug itself and have it shipped to their homes.
Eli Lilly and Company (NYSE: LLY) close up slightly on Monday at $84.81 trading over 2.9 Million shares by the market close. Lilly markets tadalafil under the trade name Cialis as an erectile dysfunction therapy, and in the summer settled a dispute with generics drugmakers that the patent on Cialis, which was previously set to expire in April 2020, will now end at the earliest in September next year.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty-one hundred dollars for news coverage of the current press release issued by RESTANCE, Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.